Emerging role of engineered exosomes in nonalcoholic fatty liver disease

被引：1
作者：
Ding, Jian [1 ]
Xu, Chen [1 ]
Xu, Ming [1 ]
He, Xiao-Yue [2 ]
Li, Wei-Na [3 ]
He, Fei [4 ,5 ]
机构：
[1] Fourth Mil Med Univ, Xi Jing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China
[2] Jining Med Univ, Affiliated Hosp Jining Med Univ, Jining 272067, Shandong, Peoples R China
[3] Fourth Mil Med Univ, Sch Basic Med, Xian 710032, Shaanxi, Peoples R China
[4] Xi Jing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China
[5] Xi Jing Hosp, Dept Hepatobiliary Surg, 127 Changle West Rd, Xian 710032, Shaanxi, Peoples R China
来源：
WORLD JOURNAL OF HEPATOLOGY | 2023年 / 15卷 / 03期
基金：
中国国家自然科学基金;
关键词：
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Exosome; Engineered exosome; Targeted therapy; HEPATOCELLULAR-CARCINOMA; DELIVERY; FIBROSIS; THERAPY;
D O I：
10.4254/wjh.v15.i3.386
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. NAFLD comprises a continuum of liver abnormalities from nonalcoholic fatty liver to nonalcoholic steatohepatitis, and can even lead to cirrhosis and liver cancer. However, a well-established treatment for NAFLD has yet to be identified. Exosomes have become an ideal drug delivery tool because of their high transmissibility, low immunogenicity, easy accessibility and targeting. Exosomes with specific modifications, known as engineered exosomes, have the potential to treat a variety of diseases. Here, we review the treatment of NAFLD with engineered exosomes and the potential use of exosomes as biomarkers and therapeutic targets for NAFLD.
引用
收藏
页码：386 / 392
页数：7
相关论文
共 53 条
[1]   Cholesterol Regulates Exosome Release in Cultured Astrocytes [J].
Abdullah, Mohammad ;
Nakamura, Tomohisa ;
Ferdous, Taslima ;
Gao, Yuan ;
Chen, Yuxin ;
Zou, Kun ;
Michikawa, Makoto .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[2]   Challenges in liver cancer and possible treatment approaches [J].
Anwanwan, David ;
Singh, Santosh Kumar ;
Singh, Shriti ;
Saikam, Varma ;
Singh, Rajesh .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2020, 1873 (01)
[3]   Exosomes: Therapy delivery tools and biomarkers of diseases [J].
Barile, Lucio ;
Vassalli, Giuseppe .
PHARMACOLOGY & THERAPEUTICS, 2017, 174 :63-78
[4]   Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice [J].
Castano, Carlos ;
Kalko, Susana ;
Novials, Anna ;
Parrizas, Marcelina .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (48) :12158-12163
[5]   Hepatic macrophages: Key players in the development and progression of liver fibrosis [J].
Cheng, Da ;
Chai, Jin ;
Wang, Huiwen ;
Fu, Lei ;
Peng, Shifang ;
Ni, Xin .
LIVER INTERNATIONAL, 2021, 41 (10) :2279-2294
[6]   Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes [J].
Crewe, Clair ;
Funcke, Jan-Bernd ;
Li, Shujuan ;
Joffin, Nolwenn ;
Gliniak, Christy M. ;
Ghaben, Alexandra L. ;
An, Yu A. ;
Sadek, Hesham A. ;
Gordillo, Ruth ;
Akgul, Yucel ;
Chen, Shiuhwei ;
Samovski, Dmitri ;
Fischer-Posovszky, Pamela ;
Kusminski, Christine M. ;
Klein, Samuel ;
Scherer, Philipp E. .
CELL METABOLISM, 2021, 33 (09) :1853-+
[7]   The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression [J].
Dabravolski, Siarhei A. ;
Bezsonov, Evgeny E. ;
Orekhov, Alexander N. .
BIOMEDICINE & PHARMACOTHERAPY, 2021, 142
[8]   Upregulation of miR-96-5p by bone marrow mesenchymal stem cells and their exosomes alleviate non-alcoholic steatohepatitis: Emphasis on caspase-2 signaling inhibition [J].
El-Derany, Marwa O. ;
AbdelHamid, Sherihan G. .
BIOCHEMICAL PHARMACOLOGY, 2021, 190
[9]   The menage a trois of autophagy, lipid droplets and liver disease [J].
Filali-Mouncef, Yasmina ;
Hunter, Catherine ;
Roccio, Federica ;
Zagkou, Stavroula ;
Dupont, Nicolas ;
Primard, Charlotte ;
Proikas-Cezanne, Tassula ;
Reggiori, Fulvio .
AUTOPHAGY, 2022, 18 (01) :50-72
[10]   MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH [J].
Gao, Hong ;
Jin, Zhongmou ;
Bandyopadhyay, Gautam ;
Rocha, Karina Cunha E. ;
Liu, Xiao ;
Zhao, Huayi ;
Zhang, Dinghong ;
Jouihan, Hani ;
Pourshahian, Soheil ;
Kisseleva, Tatiana ;
Brenner, David A. ;
Ying, Wei ;
Olefsky, Jerrold M. .
CELL METABOLISM, 2022, 34 (07) :978-+
123456